Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Optimi Health Corp. (C:OPTI)

Business Focus: Health Food Stores

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

Insider Filings

Latest 10 SEDI filings for OPTI within the last 6 months
See all filings within the past 6 months

Company News

Sep 14, 2023 14:59 ET
Optimi Health Celebrates Encouraging Results from the MAPS Phase 3 MDMA-Assisted Therapy Clinical Trial
Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a Canadian psychedelics drug research and formulation company, is pleased to see the positive and encouraging outcomes from the MAPS Phase 3 MDMA-Assisted Therapy (MDMA-AT) Clinical Trial...
Read full article
Sep 07, 2023 07:30 ET
Optimi Health Granted Amendment to Dealer's Licence by Health Canada to Supply Special Access Program
Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a Canadian psychedelics drug research and formulation company, proudly announced today that Health Canada has approved an amendment to the Company’s Dealer's Licence. The amendment empowers...
Read full article
See more news stories

Valuation Ratios

Price to Sales - TTM
Price to Book - most recent quarter
Price to Cash Flow per share - TTM
Price to Free Cash Flow per share - TTM
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Sep 15, 202318,99516,266
Aug 31, 20232,729-3,682
Aug 15, 20236,411-9,002
See Short Report

Business Summary

Sector:  Consumer Cyclicals Industry:  Miscellaneous Specialty Retailers

Optimi Health Corp. is a Canada-based company. The Company is a drug manufacturer and formulator licensed by Health Canada to produce and supply psychedelic substances, such as 3,4-Methylenedioxymethamphetamine (MDMA) and natural, Good Manufacturing Practice (GMP)-grade psilocybin, psilocin, and other psychedelic substances, some being synthetically formulated, as well as functional mushrooms that focus on domestic and international health and wellness markets. The Company owns approximately 20,000 technologically advanced manufacturing, cultivation and analytical facilities. It also invests in in providing the supply of synthetic and natural psychedelics to the international market. The Company operates as a supplier of drug and nutraceutical products serving health food distributors, and drug developers and patients regulated by Health Canada.

See business summary



Search (past week) for $OPTI.CA

  • No tweets found